Pas de connexion internet — affichage de la version enregistrée de la page.

Illumina Inc

USUSD
← Vers le screener
US:ILMNLSE:0J8Z

Illumina Inc (US:ILMN) — Medical Specialities. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 2. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site web
illumina.com
Secteur
Health Care · Medical Specialities
Siège social
San Diego, United States
Employés
9 250
Fondée
1998
Actions en circulation
151 M au 2026-07-24
Flottant
149.78 M
Capitalisation boursière
41.33 Md USD
Initiés
0.21%
Investisseurs institutionnels
106.47%
Secteur d'activité (SIC)
Laboratory Analytical Instruments
ISIN
US4523271090
LEI
SQ95QG8SR5Q56LSNF682
Description

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Bourses et tickers

BourseTickerDevisePrixType
US USA StocksILMN principaleUSD267.76 -2.11%actions ordinaires
LSE London Stock Exchange0J8Z IOBUSD270.06 +0.00%actions ordinaires

Cours sur 3 mois

jour de hausse jour de baisse date de détachement du dividende date de versementSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Dividendes

Date exVersementMontant%TypeTicker
2024-06-25—3.1051 USD1.1/1.1 %—LSE:0J8Z

Actualités de cette semaine

Communiqués de presse du site de l'entreprise pour les investisseurs, mis à jour chaque jour. Les liens mènent au site de l'entreprise. Les titres sont dans la langue originale, comme sur le site web de l'entreprise.

publicité

Principaux actionnaires

DétenteurParticipationActionsDate du rapport
Blackrock Inc.12.71%19.19 M2026-06-30
Capital World Investors10.22%15.43 M2026-06-30
Vanguard Portfolio Manag…4.39%6.63 M2026-06-30
Vanguard Capital Managem…4.36%6.59 M2026-06-30
State Street Corporation4.31%6.51 M2026-06-30
WCM Investment Managemen…4.11%6.21 M2026-06-30
iShares Trust-iShares Co…3.51%5.3 M2026-08-31
VANGUARD INDEX FUNDS-Van…3.02%4.56 M2026-06-30
FMR, LLC3%4.52 M2026-06-30
AQR Capital Management,…2.35%3.54 M2026-06-30
Primecap Management Comp…2.33%3.51 M2026-06-30
AMERICAN BALANCED FUND2.31%3.49 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.18%3.3 M2026-06-30
Geode Capital Management…1.95%2.95 M2026-06-30
Growth Fund of America1.82%2.74 M2026-06-30
New Economy Fund1.78%2.68 M2026-06-30
VANGUARD HORIZON FUNDS-V…1.17%1.76 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.15%1.74 M2026-06-30
WASHINGTON MUTUAL INVEST…1.04%1.57 M2026-07-31
NEW PERSPECTIVE FUND0.93%1.4 M2026-06-30
THAYSEN JACOB (Chief Exe…≈0.07%109 0732026-03-05
CUNNINGHAM EVERETT V (Of…≈0.03%50 8402025-03-05
BARNARD STEVEN (Chief Te…≈0.03%41 3352026-03-05
DHINGRA ANKUR (Chief Fin…≈0.02%34 2642026-03-05
PEGELS KEVIN CARL (Offic…≈0.02%29 0382026-03-05
SCHILLER PHILIP W (Direc…≈0.01%22 2202026-05-21
EPSTEIN ROBERT S (Direct…≈0.01%22 1392025-05-21
LECKMAN PATRICIA L (Offi…≈0.01%21 2592026-06-05
ARNOLD FRANCES H PH.D. (…≈0.01%20 9072025-05-21
MEISTER KEITH A (Directo…——2026-09-04